医学
多学科方法
间质细胞
放射科
多学科团队
间质瘤
梅德林
病理
医学影像学
主旨
医学物理学
重症监护医学
胃肠道
分子成像
作者
Timothy L. Arleo,Joshua Volin,Luma Abunimer,Hernan R. Bello,Noor Fatima Majeed,Wen‐Yu Hsiao,Haider A. Mejbel,Aarti K. Sekhar
出处
期刊:Radiographics
[Radiological Society of North America]
日期:2026-11-12
卷期号:46 (12): e250109-e250109
摘要
proto-oncogenes. The advent of targeted therapy for this entity in the form of a tyrosine kinase inhibitor (TKI), imatinib mesylate, has transformed the treatment for GISTs, reducing recurrence and improving survival in patients with advanced disease. Radiologists play a critical role in initial lesion identification, surgical planning, and posttherapy surveillance, with cross-sectional imaging (CT and MRI) being vital in characterizing tumor features such as endophytic or exophytic nature, pseudocapsule, ulceration, necrosis, and changes in enhancement. Incorporating the Choi criteria into routine practice further refines response assessment, guiding adjustments in therapeutic strategy. A multidisciplinary approach is essential for optimal GIST management, requiring close collaboration between surgeons, oncologists, pathologists, and radiologists to establish a diagnosis, determine resectability, consider neoadjuvant or adjuvant TKIs, and monitor for disease recurrence (with imaging intervals tailored to risk classification). Future directions involve greater incorporation of molecular profiling to personalize treatments and the integration of newer-generation TKIs for imatinib-resistant cases, highlighting the continued importance of interdisciplinary coordination.
科研通智能强力驱动
Strongly Powered by AbleSci AI